SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Feb 19, 2021–
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:
- SVB Leerink 10 th Annual Global Healthcare Conference on Friday, February 26; fireside chat at 11:20 a.m. Eastern Time.
- Cowen 41 st Annual Healthcare Conference on Thursday, March 4; fireside chat at 1:30 p.m. Eastern Time, and Synthetic Biology CEO Panel at 2:50 p.m. Eastern Time.
- Barclays Global Healthcare Conference on Tuesday, March 9; fireside chat at 10:20 a.m. Eastern Time.
The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company’s website here. A replay of the fireside chats will be archived for a period of 30 days following conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source version on businesswire.com:https://www.businesswire.com/news/home/20210219005129/en/
CONTACT: Angela Bitting
SVP, Corporate Affairs
925- 202-6211
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: HEALTH GENETICS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY
SOURCE: Twist Bioscience Corporation
Copyright Business Wire 2021.
PUB: 02/19/2021 08:00 AM/DISC: 02/19/2021 08:00 AM
http://www.businesswire.com/news/home/20210219005129/en
